Correlation Between Enlivex Therapeutics and Clinuvel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Clinuvel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Clinuvel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and Clinuvel Pharmaceuticals, you can compare the effects of market volatilities on Enlivex Therapeutics and Clinuvel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Clinuvel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Clinuvel Pharmaceuticals.

Diversification Opportunities for Enlivex Therapeutics and Clinuvel Pharmaceuticals

-0.95

Correlation Coefficient

Enlivex Therapeutics  Clinuvel Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Enlivex and Clinuvel is -0.95. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Clinuvel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clinuvel Pharmaceuticals and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Clinuvel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clinuvel Pharmaceuticals has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Clinuvel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Clinuvel Pharmaceuticals

Given the investment horizon of 90 days Enlivex Therapeutics is expected to under-perform the Clinuvel Pharmaceuticals. In addition to that, Enlivex Therapeutics is 6.39 times more volatile than Clinuvel Pharmaceuticals. It trades about -0.14 of its total potential returns per unit of risk. Clinuvel Pharmaceuticals is currently generating about 0.13 per unit of volatility. If you would invest  878.00  in Clinuvel Pharmaceuticals on March 20, 2024 and sell it today you would earn a total of  102.00  from holding Clinuvel Pharmaceuticals or generate 11.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Enlivex Therapeutics  vs.  Clinuvel Pharmaceuticals

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in July 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Clinuvel Pharmaceuticals

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Clinuvel Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, Clinuvel Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in July 2024.

Pair Trading with Enlivex Therapeutics and Clinuvel Pharmaceuticals

The main advantage of trading using opposite Enlivex Therapeutics and Clinuvel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Clinuvel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clinuvel Pharmaceuticals will offset losses from the drop in Clinuvel Pharmaceuticals' long position.

The idea behind Enlivex Therapeutics and Clinuvel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.